Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
18%
Ph not_applicable
6
55%
Ph phase_2
1
9%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
2(20.0%)
N/ANon-phased studies
6(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(1)
Other(6)

Detailed Status

unknown6
Not yet recruiting3
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (10.0%)
Phase 21 (10.0%)
Phase 32 (20.0%)
N/A6 (60.0%)

Trials by Status

recruiting19%
not_yet_recruiting327%
unknown655%
completed19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11